MedTrace Logo

Online Cognitive Behavioral Intervention Program for Hong Kong People With Depression

NCT04388800 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 402

Last updated 2023-09-22

No results posted yet for this study

Summary

The purpose of this study is to develop a culturally and linguistically appropriate online cognitive behavioral intervention program-- with therapist guidance -- for Hong Kong Chinese adults suffering from major depressive disorder with mild to moderate depressive symptoms, and examine the effectiveness of this program in reducing their depressive symptoms and improving their mental health. The 3- and 6-month maintenance effect after 3 months and 6 months will also be tested.

Conditions

Interventions

OTHER

Confront and Navigate Depression Online (CANDO)

This study adopts a blended mode of service delivery, which included both online and offline intervention. The online intervention includes 8 weekly online model, animation briefing and debriefing, case demonstration video, exercise, forum, internal messaging, reminder, online assessment, session review and online booking system. The offline intervention includes two face-to-face sessions and two telephone follow-ups.

Sponsors & Collaborators

  • Stockholm University

    collaborator OTHER

  • Richmond Fellowship of Hong Kong

    collaborator UNKNOWN

  • Caritas Wellness Link - Tsuen Wan

    collaborator UNKNOWN

  • Dr. Chiu Siu Ning

    collaborator UNKNOWN

  • Innovation and Technology Fund for Better Living

    collaborator UNKNOWN

  • Hong Kong Baptist University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04388800 on ClinicalTrials.gov